SCHEMBL19322249

SCHEMBL19322249

c1ccc2cc3c(cc2c1)[nH]c1c2cc4ccccc4nc2[nH]c31

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.50
PDE3A Q14432 3/20 0.50
PDE2A O00408 2/20 0.50
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
GLA P06280 2/20 0.41
ACHE P22303 1/20 0.41
NQO2 P16083 1/20 0.39
KDM4E B2RXH2 4/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 3/20 0.39
LMNA P02545 3/20 0.39
GAA P10253 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
PTBP1 P26599 1/20 0.39
RCE1 Q9Y256 1/20 0.39
TP53 P04637 1/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19322145 0.89 ALDH1A1 (0.50) PDE3BPDE3APDE2AMAPTALDH1A1
SCHEMBL17779364 0.82 KDM4E (0.50) PDE3BPDE3AMAPTALDH1A1HPGD
SCHEMBL2422471 0.74 POLB (0.58) PDE3BPDE3APDE2AMAPTALDH1A1
SCHEMBL17775035 0.70 KIF11 (0.55) PDE3BPDE3AMAPTALDH1A1HPGD
SCHEMBL12219483 0.70 KDM4E (0.46) PDE3BPDE3AMAPTALDH1A1KDM4E
SCHEMBL29385786 0.69 AHR (0.56) PDE3BPDE3AMAPTALDH1A1HPGD
SCHEMBL10743051 0.69 AHR (0.56) PDE3BPDE3AMAPTALDH1A1HPGD
SCHEMBL24806927 0.68 KIF11 (0.63) ALDH1A1HSD17B10TOP2AHTR2BHTR5A
SCHEMBL29407008 0.68 PDE3B (0.65) PDE3BPDE3APDE2AMAPTALDH1A1
SCHEMBL18227086 0.68 PDE2A (0.51) PDE3BPDE3APDE2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170256721-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY (KR) 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256721-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME C1R, C1S, CCNT1 PDE3B 3776/4885PDE3A 3958/4885PDE2A 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.